GRACEcast สาธารณะ
[search 0]
เพิ่มเติม

ดาวน์โหลดแอปเลย!

show episodes
 
G
GRACEcast

1
GRACEcast

cancerGRACE - H. Jack West, MD

Unsubscribe
Unsubscribe
รายเดือน
 
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.
 
Loading …
show series
 
Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.โดย cancerGRACE - H. Jack West, MD
 
What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.โดย cancerGRACE - H. Jack West, MD
 
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.โดย cancerGRACE - H. Jack West, MD
 
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.โดย cancerGRACE - H. Jack West, MD
 
Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.โดย cancerGRACE - H. Jack West, MD
 
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.โดย cancerGRACE - H. Jack West, MD
 
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.โดย cancerGRACE - H. Jack West, MD
 
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.โดย cancerGRACE - H. Jack West, MD
 
Loading …

คู่มืออ้างอิงด่วน

Google login Twitter login Classic login